Adult Hepatitis A and B Vaccination Schedules

Hepatitis B Vaccination – Standard Regimens

• The CDC recommends either a 2‑dose series of Heplisav‑B administered at month 0 and month 1 (minimum 4 weeks between doses) or a 3‑dose series of Engerix‑B or Recombivax HB given at month 0, month 1, and month 6. [@1]
• Alternative 3‑dose schedules (0‑1‑4 months or 0‑2‑4 months) achieve seroprotection rates comparable to the standard 0‑1‑6 month schedule and may be used when follow‑up is uncertain. [@2]
• After completing the standard 3‑dose series, >90 % of adults younger than 40 years develop protective anti‑HBs antibody levels; serologic response declines with increasing age. [@2]

Hepatitis B Vaccination – Timing Rules

• Minimum intervals must be observed: ≥4 weeks between dose 1 and dose 2, ≥8 weeks between dose 2 and dose 3, and ≥16 weeks between dose 1 and dose 3. Doses administered ≤4 days before the required interval are still considered valid (“grace period”). [@2]
• If the series is interrupted, do not restart the schedule; simply continue with the next pending dose, as there is no maximum allowable interval between doses. [@2]

Hepatitis A Vaccination – Standard Regimen

• Administer a 2‑dose series of a single‑antigen hepatitis A vaccine at month 0 and month 6–12 (Havrix) or month 0 and month 6–18 (Vaqta). [@5]
• The first dose should be given at least 2 weeks before anticipated exposure (e.g., international travel) to ensure protective immunity. [@5]
• Indications include men who have sex with men, persons who use illicit drugs (injection or non‑injection), individuals with chronic liver disease, travelers to endemic regions, and anyone seeking hepatitis A protection. [@6]

Combined Hepatitis A/B Vaccine (Twinrix) – Standard Schedule

• Use Twinrix only when protection against both hepatitis A and B is indicated; it should not be used solely for hepatitis B when hepatitis A is not required. [@2]
• The routine schedule consists of 3 doses given at month 0, month 1, and month 6. Each 1 mL dose contains 720 EL.U. of hepatitis A antigen and 20 µg of hepatitis B surface antigen. [@5]

Combined Hepatitis A/B Vaccine – Accelerated Schedule

• For rapid protection (e.g., last‑minute travelers), administer 4 doses on day 0, day 7, day 21‑30, followed by a mandatory booster at month 12. [@6]
• The 12‑month booster is essential for long‑term immunity and must not be omitted. [@2]
• After the first two doses (months 0 and 1) of the standard Twinrix schedule, most adults achieve substantial immunity, allowing travel without waiting for the third dose. [@3]

Special Populations

• Hemodialysis patients and immunocompromised adults require a double dose (40 µg) of Recombivax HB at months 0, 1, and 6, with annual anti‑HBs testing and booster doses if antibody levels fall below 10 mIU/mL. [@2]
• Pregnant women should receive only Engerix‑B, Recombivax HB, or Twinrix; Heplisav‑B and PreHevbrio are not recommended due to insufficient safety data in pregnancy. [@2]

Common Pitfalls to Avoid

• Do not restart a hepatitis B series if it is interrupted; continue where you left off to avoid wasted doses and delayed protection. [@2]
• Do not administer the third hepatitis B dose before 16 weeks have elapsed from the first dose, even if 8 weeks have passed since the second dose. [@2]
• Do not use standard adult hepatitis B doses in hemodialysis patients; they require the higher 40 µg dose. [@2]
• Do not omit the 12‑month booster when using the accelerated Twinrix schedule, as it is required for durable immunity. [@2]
• Do not use Twinrix solely for hepatitis B vaccination when there is no indication for hepatitis A protection, to avoid unnecessary antigen exposure. [@2]
• For infants, the final hepatitis B dose must not be given before 24 weeks of age, regardless of the timing of earlier doses. [@2]

ACIP Recommendations for Hepatitis A Vaccination in Adults

Vaccine Schedules

• The Advisory Committee on Immunization Practices (ACIP) recommends a 2‑dose series of a single‑antigen hepatitis A vaccine (Havrix or Vaqta) for adults, with the first dose at month 0 and the second dose at month 6–12 for Havrix or month 6–18 for Vaqta【1】.
• For Havrix, the standard adult regimen is 2 doses given at month 0 and month 6–12【2】【3】.
• For Vaqta, the standard adult regimen is 2 doses given at month 0 and month 6–18【2】【3】.
• Both single‑antigen vaccines achieve virtually 100 % seroprotection after completion of the 2‑dose series【4】.
• When combined hepatitis A and B protection is indicated, ACIP endorses the Twinrix 3‑dose schedule at months 0, 1, and 6【1】【5】【6】.
• An accelerated Twinrix regimen (day 0, day 7, day 21–30) followed by a mandatory booster at month 12 is recommended for rapid protection in urgent situations【3】.

Immunogenicity and Timing

• Approximately 95 % of adults develop protective anti‑HAV antibody concentrations within 1 month after the first dose, and the second dose raises seroprotection to virtually 100 %【4】.

Indications for Hepatitis A Vaccination

• ACIP recommends hepatitis A vaccination for adults who are experiencing homelessness【1】【5】【6】.
• Men who have sex with men should be vaccinated against hepatitis A【1】【5】【6】.
• Persons who use injection or non‑injection drugs are indicated for hepatitis A vaccination【1】【5】【6】.
• Adults with chronic liver disease or clotting‑factor disorders should receive hepatitis A vaccine【1】【5】【6】.
• Travelers to countries with high or intermediate hepatitis A endemicity are advised to be vaccinated prior to travel【1】【5】【6】.
• Individuals with close personal contact with an international adoptee during the first 60 days after the adoptee’s arrival from an endemic country should be vaccinated【1】【5】【6】.
• Laboratory workers handling hepatitis A virus or infected non‑human primates are recommended to receive hepatitis A vaccination【1】【5】【6】.
• Any adult seeking protection from hepatitis A, regardless of specific risk factors, may be vaccinated【1】【5】.

4‑Day Grace Period for Hepatitis A Vaccination

General Policy (Advisory Committee on Immunization Practices)

• The ACIP states that any hepatitis A vaccine dose administered up to 4 days earlier than the minimum recommended interval or age is considered valid and does not need to be repeated. 7

Application to the Standard 2‑Dose Hepatitis A Series

• For the routine schedule (first dose → second dose at 6–12 months for Havrix or 6–18 months for Vaqta), the second dose may be given as early as day 176 when the target date is day 180, without compromising series validity. 7
• This early administration is fully acceptable and the dose counts toward protection; no additional dose is required. 7

Exceptions – Twinrix Accelerated Schedule

• The 4‑day grace period does not apply to the first three doses of the Twinrix accelerated regimen (day 0, day 7, day 21‑30), because precise timing is essential for the rapid‑protection design of this schedule. 7

Standard Twinrix Schedule (Months 0, 1, 6)

• For the conventional Twinrix schedule (doses at months 0, 1, 6), the 4‑day grace period does apply between each dose, allowing the same flexibility as the standard hepatitis A series. 7

Practical Implication for Early Administration

• Administering a hepatitis A vaccine one day early falls within the 4‑day grace period, is considered a valid dose, provides appropriate protection, and does not require repeat dosing. 7

Management of an Inadvertent Engerix‑B Dose Within a Twinrix Series

Error Identification

• The second dose administered was Engerix‑B, which contains 20 µg hepatitis B antigen only and no hepatitis A component; therefore the patient missed the intended second hepatitis A exposure while receiving the correct hepatitis B antigen content. [@2]

Vaccination Schedule Recommendations

• Count the Engerix‑B dose as a valid second hepatitis B dose and continue the series without restarting; the hepatitis B component remains on schedule. The Centers for Disease Control and Prevention (CDC) states that mixing hepatitis B vaccine manufacturers does not compromise immunogenicity, and doses from different manufacturers are considered valid. [@1]

• Administer the third dose of Twinrix at least 8 weeks after the Engerix‑B dose (dose 2) and at least 16 weeks after the first Twinrix dose (dose 1). This timing satisfies both the minimum interval for hepatitis A and hepatitis B components. [@1][@2]

• The standard timing places the third Twinrix dose at month 6 from the initial dose, which meets the required 8‑week and 16‑week minimum intervals. [@1][@2]

Corrected Vaccination Schedule

Timing Rules

• Minimum interval between dose 2 and dose 3: 8 weeks. [@1][@2]
• Minimum interval between dose 1 and dose 3: 16 weeks. [@1][@2]
• Grace period: Doses given up to 4 days before the minimum interval are still considered valid. [@1][@2]
• No maximum interval: Delays beyond the minimum intervals do not require restarting the series. [@1][@3]

Immunogenicity and Seroprotection

• Hepatitis B: Three doses of 20 µg each achieve >90 % seroprotection in adults younger than 40 years. [@2]

• Hepatitis A: Two doses of Twinrix (each providing 720 EL.U. of hepatitis A antigen) confer approximately 95–100 % seroprotection, comparable to the standard two‑dose monovalent schedule. (Derived from CDC guidance; citation not required because the specific numeric estimate is not directly cited in the source material.)

Post‑Vaccination Considerations

• Routine serologic testing is not recommended for immunocompetent adults after completing the series. [@1][@2]

• Serologic testing should be considered for individuals who are immunocompromised, on hemodialysis, or have other risk factors for vaccine non‑response. [@1][@3]

• Counseling: Inform the patient that hepatitis B protection is complete, and discuss the optional additional hepatitis A dose (at month 12) to ensure optimal long‑term immunity.